Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy.
Masui Y, Shukuya T, Kataoka S, Shiozaki H, Kurokawa K, Nakamura I, Miyawaki T, Koinuma Y, Asao T, Kanemaru R, Shimamura SS, Mimori T, Mitsuishi Y, Tajima K, Shimada N, Takahashi K.
Masui Y, et al. Among authors: nakamura i.
Thorac Cancer. 2024 Nov;15(32):2291-2297. doi: 10.1111/1759-7714.15457. Epub 2024 Oct 7.
Thorac Cancer. 2024.
PMID: 39375951
Free PMC article.